Submit an Article
Navigate
Home
Editorial Board
Editorial Policies
Current Volume
Archive
Scientific Integrity
Publication Ethics Statements
Interviews with Outstanding Authors
Newsroom
Sponsored Conferences
Podcast
Contact
Special Collections
Submit an Article
Online ISSN: 1945-4589
Research Paper
|
Volume 16, Issue 2
|
pp. 1218–1236
Development and validation of a combined cuproptosis and immunogenic cell death prognostic model for diffuse large B-cell lymphoma
Back to article
Figure 8
(8 of 8)
−
100%
+
Figure 8.
Validation the expression of CRIRLs.
(
A
) ANKRD10-IT1, (
B
) HOXB-AS1, (
C
) LINC00520, (
D
) LINC01165 expression in human B lymphoid cell line and human DLBCL cell lines.
*
P
< 0.05;
**
P
< 0.01;
***
P
< 0.001.
